mTOR, translation initiation and cancer
The DOI matches its Crossref record; 79 of the 79 references it cites were found in a registry or an index.
Abstract
Control of mRNA translation plays a fundamental role in many aspects of cell metabolism. It constitutes a critical step in the control of gene expression, and consequently cell growth, proliferation and differentiation. Translation is regulated in response to nutrient availability, hormones, mitogenic and growth factor stimulation and is coupled with cell cycle progression and cell growth. Signaling by the PI3K/Akt/mTOR pathway profoundly affects mRNA translation through phosphorylation of downstream targets such as 4E-BP and S6K. Inhibitors of this pathway and thus cap-dependent translation are emerging as promising therapeutic options for the treatment of cancer.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Such a shift has been associated with proliferation in tumorigenesis, and has been linked to the translational control of RPs (Mamane et al., 2006; Ruggero and Sonenberg, 2005).”
From Ribosome Profiling of Mouse Embryonic Stem Cells Reveals the Complexity and Dynamics of Mammalian Proteomes (2011) · cites this paper as Mamane et al., 2006
Citations
Cites
Upstream and downstream of mTOR
Hay, N., & Sonenberg, N. (2004) · Genes & Development · doi:10.1101/gad.1212704 · Cited by 4,181 · cited 5×
“…factors and hormones) with aminoacid availability and intracellular energy status to control translation rates and additional metabolic processes (Hay and Sonenberg, 2004) (Figure 2). mTOR has received considerable attention, as rapamycin (Rapamune) is a specific inhibitor of mTOR activity (for…”
BackgroundInfluentialSelf-citationExploiting the PI3K/AKT Pathway for Cancer Drug Discovery
Hennessy, B. T., Smith, D. L., Ram, P. T., Lu, Y., & Mills, G. B. (2005) · Nature Reviews Drug Discovery · doi:10.1038/nrd1902 · Cited by 2,185 · cited 1×
“An important downstream target of this signaling pathway is cap-dependent mRNA translation (Hay and Sonenberg, 2004; Hennessy et al., 2005; Stephens et al., 2005; Petroulakis et al., 2006) (Figure 2). mTOR promotes the phosphorylation and activation of S6K and the hierarchial phosphorylation the…”
BackgroundeIF4 Initiation Factors: Effectors of mRNA Recruitment to Ribosomes and Regulators of Translation
Gingras, A.-C., Raught, B., & Sonenberg, N. (1999) · Annual Review of Biochemistry · doi:10.1146/annurev.biochem.68.1.913 · Cited by 2,121 · cited 4×
“The cap structure, m7GpppN (where N is any nucleotide), is present at the 50 terminus of all cellular eucaryotic mRNAs (except those in organelles) (Gingras et al., 1999b).”
BackgroundInfluentialSelf-citationRegulation of 4E-BP1 phosphorylation: a novel two-step mechanism
Gingras, A.-C., Gygi, S. P., Raught, B., Polakiewicz, R. D., Abraham, R. T., Hoekstra, M. F., Aebersold, R., & Sonenberg, N. (1999) · Genes & Development · doi:10.1101/gad.13.11.1422 · Cited by 1,343 · cited 4×
“The cap structure, m7GpppN (where N is any nucleotide), is present at the 50 terminus of all cellular eucaryotic mRNAs (except those in organelles) (Gingras et al., 1999b).”
BackgroundInfluentialSelf-citationHolz, M. K., Ballif, B. A., Gygi, S. P., & Blenis, J. (2005) · Cell · doi:10.1016/j.cell.2005.10.024 · Cited by 1,262
Pause, A., Belsham, G. J., Gingras, A.-C., Donzé, O., Lin, T.-A., Lawrence, J. C., & Sonenberg, N. (1994) · Nature · doi:10.1038/371762a0 · Cited by 1,239 · cited 1×
“…Heat and Acid-Stable protein regulated by Insulin) and 4E-BP2, were identified in a screen using radiolabelled recombinant eIF4E protein to probe a human placenta expression library (Pause et al., 1994) and by sequencing the complementary DNA (cDNA) clone for PHAS-I (Hu et al., 1994).”
BackgroundSelf-citationMammalian cell size is controlled by mTOR and its downstream targets S6K1 and 4EBP1/eIF4E
Fingar, D. C., Salama, S., Tsou, C., Harlow, E., & Blenis, J. (2002) · Genes & Development · doi:10.1101/gad.995802 · Cited by 1,093 · cited 1×
“Enhancement of the eIF4E/4E-BP interaction, through the expression of a constitutively active 4E-BP mutant (all phosphorylation sites mutated to Ala), leads to a decrease in cell size and inhibition of cell cycle progression in a manner that mimics rapamycin treatment (Fingar et al., 2002, 2004).”
BackgroundKim, D.-H., Sarbassov, D. D., Ali, S. M., Latek, R. R., Guntur, K. V. P., Erdjument-Bromage, H., Tempst, P., & Sabatini, D. M. (2003) · Molecular Cell · doi:10.1016/s1097-2765(03)00114-x · Cited by 961 · cited 1×
“…et al., 2005; Stephens et al., 2005; Petroulakis et al., 2006) (Figure 2). mTOR promotes the phosphorylation and activation of S6K and the hierarchial phosphorylation the 4E-BPs (Gingras et al., 2001; Jacinto and Hall, 2003; Kim et al., 2003; Ruggero and Pandolfi, 2003; Kim and Sabatini, 2004).”
BackgroundMalignant transformation by a eukaryotic initiation factor subunit that binds to mRNA 5' cap
Lazaris-Karatzas, A., Montine, K. S., & Sonenberg, N. (1990) · Nature · doi:10.1038/345544a0 · Cited by 956 · cited 1×
“…binding (Gingras et al., 1999b). eIF4G recruits the 40S small ribosomal subunit to the mRNA through the ribosomeassociated eIF3. eIF4E eIF4E was the first translation factor shown to cause malignant transformation when overexpressed in cul- tured rodent cells (Lazaris-Karatzas et al., 1990).”
BackgroundSelf-citationSurvival signalling by Akt and eIF4E in oncogenesis and cancer therapy
Wendel, H.-G., Stanchina, E. D., Fridman, J. S., Malina, A., Ray, S., Kogan, S., Cordon-Cardo, C., Pelletier, J., & Lowe, S. W. (2004) · Nature · doi:10.1038/nature02369 · Cited by 951 · cited 1×
“Furthermore, two groups independently demonstrated that eIF4E promotes lymphomagenesis in cooperation with Myc in transgenic mice (Ruggero et al., 2004; Wendel et al., 2004).”
BackgroundMitogen-activated protein kinases activate the serine/threonine kinases Mnk1 and Mnk2
Waskiewicz, A. J. (1997) · The EMBO Journal · doi:10.1093/emboj/16.8.1909 · Cited by 947 · cited 1×
“(2) Phosphorylation: eIF4E undergoes phosphorylation at Ser209 by MAP kinase signaling integration kinases 1 and 2 (Mnk1/2) (Fukunaga and Hunter, 1997; Waskiewicz et al., 1997). eIF4E phosphorylation appears to enhance its transformation potential (Topisirovic et al., 2004).”
BackgroundDoes the ribosome translate cancer?
Ruggero, D., & Pandolfi, P. P. (2003) · Nature Reviews Cancer · doi:10.1038/nrc1015 · Cited by 928 · cited 1×
“…et al., 2005; Stephens et al., 2005; Petroulakis et al., 2006) (Figure 2). mTOR promotes the phosphorylation and activation of S6K and the hierarchial phosphorylation the 4E-BPs (Gingras et al., 2001; Jacinto and Hall, 2003; Kim et al., 2003; Ruggero and Pandolfi, 2003; Kim and Sabatini, 2004).”
BackgroundHierarchical phosphorylation of the translation inhibitor 4E-BP1
Gingras, A.-C., Raught, B., Gygi, S. P., Niedzwiecka, A., Miron, M., Burley, S. K., Polakiewicz, R. D., Wyslouch-Cieszynska, A., Aebersold, R., & Sonenberg, N. (2001) · Genes & Development · doi:10.1101/gad.912401 · Cited by 883
Self-citationTRAIL and apoptosis induction by TNF-family death receptors
Wang, S., & El-Deiry, W. S. (2003) · Oncogene · doi:10.1038/sj.onc.1207232 · Cited by 871 · cited 2×
“TRAIL (tumor necrosis factor-related apoptosis-inducing ligand) is a mediator of anti-tumor drug activity, and a promising target for the treatment of cancer (Wang and El-Deiry, 2003).”
BackgroundFingar, D. C., Richardson, C. J., Tee, A. R., Cheatham, L., Tsou, C., & Blenis, J. (2004) · Molecular and Cellular Biology · doi:10.1128/mcb.24.1.200-216.2004 · Cited by 868 · cited 1×
“Enhancement of the eIF4E/4E-BP interaction, through the expression of a constitutively active 4E-BP mutant (all phosphorylation sites mutated to Ala), leads to a decrease in cell size and inhibition of cell cycle progression in a manner that mimics rapamycin treatment (Fingar et al., 2002, 2004).”
BackgroundPende, M., Um, S. H., Mieulet, V., Sticker, M., Goss, V. L., Mestan, J., Mueller, M., Fumagalli, S., Kozma, S. C., & Thomas, G. (2004) · Molecular and Cellular Biology · doi:10.1128/mcb.24.8.3112-3124.2004 · Cited by 742 · cited 2×
“A role for the S6 kinases in controlling the cell size has been suggested as their deletion results in smaller animals (Pende et al., 2004).”
BackgroundFukunaga, R. (1997) · The EMBO Journal · doi:10.1093/emboj/16.8.1921 · Cited by 663 · cited 1×
“(2) Phosphorylation: eIF4E undergoes phosphorylation at Ser209 by MAP kinase signaling integration kinases 1 and 2 (Mnk1/2) (Fukunaga and Hunter, 1997; Waskiewicz et al., 1997). eIF4E phosphorylation appears to enhance its transformation potential (Topisirovic et al., 2004).”
BackgroundDisruption of the p70s6k/p85s6k gene reveals a small mouse phenotype and a new functional S6 kinase
Shima, H. (1998) · The EMBO Journal · doi:10.1093/emboj/17.22.6649 · Cited by 636 · cited 1×
“Mammalian cells contain two ribosomal protein S6 kinases (S6K1 and S6K2) encoded by two separate genes (Shima et al., 1998).”
BackgroundAkt Maintains Cell Size and Survival by Increasing mTOR-dependent Nutrient Uptake
Edinger, A. L., & Thompson, C. B. (2002) · Molecular Biology of the Cell · doi:10.1091/mbc.01-12-0584 · Cited by 589 · cited 1×
“…2004). eIF4E also blocks endoplasmic reticulum- and p53-mediated apoptosis (Li et al., 2004; Mungamuri et al., 2006). mTOR controls cell survival (Edinger and Thompson, 2002; Mungamuri et al., 2006). eIF4E could serve as an important downstream effector of mTOR in the control of cell survival…”
BackgroundThe translation factor eIF-4E promotes tumor formation and cooperates with c-Myc in lymphomagenesis
Ruggero, D., Montanaro, L., Ma, L., Xu, W., Londei, P., Cordon-Cardo, C., & Pandolfi, P. P. (2004) · Nature Medicine · doi:10.1038/nm1042 · Cited by 586 · cited 2×
“Furthermore, two groups independently demonstrated that eIF4E promotes lymphomagenesis in cooperation with Myc in transgenic mice (Ruggero et al., 2004; Wendel et al., 2004).”
BackgroundTOR signalling in bugs, brain and brawn
Jacinto, E., & Hall, M. N. (2003) · Nature Reviews Molecular Cell Biology · doi:10.1038/nrm1018 · Cited by 565 · cited 1×
“…et al., 2005; Stephens et al., 2005; Petroulakis et al., 2006) (Figure 2). mTOR promotes the phosphorylation and activation of S6K and the hierarchial phosphorylation the 4E-BPs (Gingras et al., 2001; Jacinto and Hall, 2003; Kim et al., 2003; Ruggero and Pandolfi, 2003; Kim and Sabatini, 2004).”
BackgroundThe mTOR/PI3K and MAPK pathways converge on eIF4B to control its phosphorylation and activity
Shahbazian, D., Roux, P. P., Mieulet, V., Cohen, M. S., Raught, B., Taunton, J., Hershey, J. W., Blenis, J., Pende, M., & Sonenberg, N. (2006) · The EMBO Journal · doi:10.1038/sj.emboj.7601166 · Cited by 531 · cited 2×
“Oncogene eIF4B undergoes phosphorylation not only by the PI3K/mTOR pathway, but also by the ERK 1/2 MAPK pathway (Shahbazian et al., 2006).”
BackgroundSelf-citationCap-Dependent Translation Initiation in Eukaryotes Is Regulated by a Molecular Mimic of eIF4G
Marcotrigiano, J., Gingras, A.-C., Sonenberg, N., & Burley, S. K. (1999) · Molecular Cell · doi:10.1016/s1097-2765(01)80003-4 · Cited by 512 · cited 1×
“Structural studies have demonstrated that the eIF4Gs and the 4E-BPs interact through mutually exclusive binding sites on the surface of eIF4E (Marcotrigiano et al., 1999).”
BackgroundSelf-citationSynthesis of the translational apparatus is regulated at the translational level
Meyuhas, O. (2000) · European Journal of Biochemistry · doi:10.1046/j.1432-1327.2000.01719.x · Cited by 509 · cited 1×
“It was thought that S6Ks are critical for translation of mRNAs that bear a terminal oligo pyrimidine (TOP) sequence in their 50UTR (reviewed in Meyuhas, 2000).”
BackgroundDuncan, R., Milburn, S. C., & Hershey, J. W. (1987) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(19)75938-9 · Cited by 482
eIF4E – from translation to transformation
Mamane, Y., Petroulakis, E., Rong, L., Yoshida, K., Ler, L. W., & Sonenberg, N. (2004) · Oncogene · doi:10.1038/sj.onc.1207549 · Cited by 449 · cited 1×
“Indeed, overexpression of eIF4E leads to enhanced translation of many highly structured mRNAs, which are implicated in cell growth, proliferation and survival (reviewed in Mamane et al., 2004).”
BackgroundSelf-citationVascular endothelial growth factor expression in early stage ovarian carcinoma
Paley, P. J., Staskus, K. A., Gebhard, K., Mohanraj, D., Twiggs, L. B., Carson, L. F., & Ramakrishnan, S. (1997) · Cancer · doi:10.1002/(sici)1097-0142(19970701)80:1<98::aid-cncr13>3.0.co;2-a · Cited by 364 · cited 1×
“VEGF is essential for both physiological and pathological angiogenesis in cancer, such as ovarian cancers (Paley et al., 1997; Wang et al., 2006).”
BackgroundAvdulov, S., Li, S., Michalek, V., Burrichter, D., Peterson, M., Perlman, D. M., Manivel, J. C., Sonenberg, N., Yee, D., Bitterman, P. B., et al. (2004) · Cancer Cell · doi:10.1016/j.ccr.2004.05.024 · Cited by 340 · cited 2×
“This 4E-BP mutant also slows G1 progression, blocks c-myc-induced transformation (Lynch et al., 2004) and prevents tumor growth (Avdulov et al., 2004).”
BackgroundSelf-citationTang, H., Hornstein, E., Stolovich, M., Levy, G., Livingstone, M., Templeton, D., Avruch, J., & Meyuhas, O. (2001) · Molecular and Cellular Biology · doi:10.1128/mcb.21.24.8671-8683.2001 · Cited by 304 · cited 1×
“This agrees with earlier results showing that amino acid dependent or mitogenic-stimulated translation of TOP mRNAs is dependent on PI3Kmediated signaling, but requires neither S6K1 nor ribosomal protein S6 phosphorylation (Tang et al., 2001; Stolovich et al., 2002).”
Result4E-BP3, a New Member of the Eukaryotic Initiation Factor 4E-binding Protein Family
Poulin, F., Gingras, A.-C., Olsen, H., Chevalier, S., & Sonenberg, N. (1998) · Journal of Biological Chemistry · doi:10.1074/jbc.273.22.14002 · Cited by 300 · cited 1×
“A third mammalian homolog, 4E-BP3, was later isolated from a prostate cancer cell line cDNA library (Poulin et al., 1998).”
BackgroundSelf-citationRaught, B. (2000) · The EMBO Journal · doi:10.1093/emboj/19.3.434 · Cited by 270 · cited 1×
“…overexpressed in squamous cell lung carcinomas (Brass et al., 1997; Keiper et al., 1999; Bauer et al., 2001, 2002), and eIF4GI transforms NIH 3T3 cells (Fukuchi-Shimogori et al., 1997). eIF4GI is a downstream target of mTOR as rapamycin treatment inhibits its phosphorylation (Raught et al., 2000).”
BackgroundSelf-citationTopisirovic, I., Ruiz-Gutierrez, M., & Borden, K. L. B. (2004) · Cancer Research · doi:10.1158/0008-5472.can-04-2677 · Cited by 257 · cited 1×
“(2) Phosphorylation: eIF4E undergoes phosphorylation at Ser209 by MAP kinase signaling integration kinases 1 and 2 (Mnk1/2) (Fukunaga and Hunter, 1997; Waskiewicz et al., 1997). eIF4E phosphorylation appears to enhance its transformation potential (Topisirovic et al., 2004).”
BackgroundSurvival Signaling by Notch1: Mammalian Target of Rapamycin (mTOR)–Dependent Inhibition of p53
Mungamuri, S. K., Yang, X., Thor, A. D., & Somasundaram, K. (2006) · Cancer Research · doi:10.1158/0008-5472.can-05-3830 · Cited by 246 · cited 2×
“…induced cell death in transgenic mice (Ruggero et al., 2004). eIF4E also blocks endoplasmic reticulum- and p53-mediated apoptosis (Li et al., 2004; Mungamuri et al., 2006). mTOR controls cell survival (Edinger and Thompson, 2002; Mungamuri et al., 2006). eIF4E could serve as an important…”
BackgroundYamanaka, S., Poksay, K. S., Arnold, K. S., & Innerarity, T. L. (1997) · Genes & Development · doi:10.1101/gad.11.3.321 · Cited by 229 · cited 1×
“Other eIFs are also involved in cell survival. p97/NAT-1/DAP5, a member of the eIF4G family, which acts as a general translational inhibitor (Imataka et al., 1997; Yamanaka et al., 1997), but stimulates translation of its own mRNA (Henis-Korenblit et al., 2002), also plays a role in apoptosis.”
BackgroundStolovich, M., Tang, H., Hornstein, E., Levy, G., Cohen, R., Bae, S. S., Birnbaum, M. J., & Meyuhas, O. (2002) · Molecular and Cellular Biology · doi:10.1128/mcb.22.23.8101-8113.2002 · Cited by 228 · cited 1×
“This agrees with earlier results showing that amino acid dependent or mitogenic-stimulated translation of TOP mRNAs is dependent on PI3Kmediated signaling, but requires neither S6K1 nor ribosomal protein S6 phosphorylation (Tang et al., 2001; Stolovich et al., 2002).”
ResultThe TOR signalling network from yeast to man
De Virgilio, C., & Loewith, R. (2006) · The International Journal of Biochemistry & Cell Biology · doi:10.1016/j.biocel.2006.02.013 · Cited by 227 · cited 1×
“…energy status to control translation rates and additional metabolic processes (Hay and Sonenberg, 2004) (Figure 2). mTOR has received considerable attention, as rapamycin (Rapamune) is a specific inhibitor of mTOR activity (for review see Hay and Sonenberg, 2004; De Virgilio and Loewith, 2006).”
BackgroundA new translational regulator with homology to eukaryotic translation initiation factor 4G
Imataka, H. (1997) · The EMBO Journal · doi:10.1093/emboj/16.4.817 · Cited by 223 · cited 1×
“Other eIFs are also involved in cell survival. p97/NAT-1/DAP5, a member of the eIF4G family, which acts as a general translational inhibitor (Imataka et al., 1997; Yamanaka et al., 1997), but stimulates translation of its own mRNA (Henis-Korenblit et al., 2002), also plays a role in apoptosis.”
BackgroundSelf-citationHuang, S., Shu, L., Dilling, M. B., Easton, J., Harwood, F. C., Ichijo, H., & Houghton, P. J. (2003) · Molecular Cell · doi:10.1016/s1097-2765(03)00180-1 · Cited by 216 · cited 2×
“Rapamycin induced cell death by JNK activation occurs only in the absence of p53 (Huang et al., 2003).”
BackgroundImmunological detection of the messenger RNA cap-binding protein.
Hiremath, L. S., Webb, N. R., & Rhoads, R. E. (1985) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(17)39529-7 · Cited by 200
Skinner, H. D., Zheng, J. Z., Fang, J., Agani, F., & Jiang, B.-H. (2004) · Journal of Biological Chemistry · doi:10.1074/jbc.m404097200 · Cited by 192 · cited 3×
“Consistent with this, S6K1 overexpression reversed the LY294002-mediated inhibition of VEGF expression (Skinner et al., 2004).”
BackgroundGrolleau, A., Bowman, J., Pradet-Balade, B., Puravs, E., Hanash, S., Garcia-Sanz, J. A., & Beretta, L. (2002) · Journal of Biological Chemistry · doi:10.1074/jbc.m202014200 · Cited by 187 · cited 1×
“Rapamycin treatment inhibits 4E-BP phosphorylation, increases the interaction between eIF4E and 4E-BP, and consequently inhibits cap-dependent translation (Gingras et al., 2001; Grolleau et al., 2002).”
BackgroundmTOR‐dependent stimulation of the association of eIF4G and eIF3 by insulin
Harris, T. E., Chi, A., Shabanowitz, J., Hunt, D. F., Rhoads, R. E., & Lawrence, J. C. (2006) · The EMBO Journal · doi:10.1038/sj.emboj.7601047 · Cited by 173 · cited 1×
“The interaction of mTOR with eIF3 also augments the association between eIF3 and eIF4G (Harris et al., 2006).”
BackgroundmTOR signaling: implications for cancer and anticancer therapy
Petroulakis, E., Mamane, Y., Le Bacquer, O., Shahbazian, D., & Sonenberg, N. (2006) · British Journal of Cancer · doi:10.1038/sj.bjc.6602902 · Cited by 170 · cited 1×
“…target of this signaling pathway is cap-dependent mRNA translation (Hay and Sonenberg, 2004; Hennessy et al., 2005; Stephens et al., 2005; Petroulakis et al., 2006) (Figure 2). mTOR promotes the phosphorylation and activation of S6K and the hierarchial phosphorylation the 4E-BPs (Gingras…”
BackgroundSelf-citationLazaris-Karatzas, A., & Sonenberg, N. (1992) · Molecular and Cellular Biology · doi:10.1128/mcb.12.3.1234 · Cited by 168
Self-citationThe role of c-myc in regulation of translation initiation
Schmidt, E. V. (2004) · Oncogene · doi:10.1038/sj.onc.1207548 · Cited by 166 · cited 8×
“It is noteworthy that the mRNAs encoding several protein inhibitors of apoptosis (XIAP, c-IAP1 and BCl-2) and pro-apoptotic proteins (c-Myc, APAF-1) contain internal ribosomal entry sites (IRES), which serve to sustain translation during apoptosis, when cap-dependent expression is suppressed (reviewed in Proud, 2004).”
BackgroundInfluentialPolunovsky, V. A., Rosenwald, I. B., Tan, A. T., White, J., Chiang, L., Sonenberg, N., & Bitterman, P. B. (1996) · Molecular and Cellular Biology · doi:10.1128/mcb.16.11.6573 · Cited by 165 · cited 1×
“…and cell death. eIF4E plays an important role in the control of this balance (Tan et al., 2000; Clemens, 2001; Dua et al., 2001; Li et al., 2003, 2004). eIF4E overexpression compensates for serum/growth factor deprivation by promoting the survival of NIH 3T3 cells (Polunovsky et al., 1996).”
BackgroundSelf-citationHenis-Korenblit, S., Shani, G., Sines, T., Marash, L., Shohat, G., & Kimchi, A. (2002) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.082102499 · Cited by 163 · cited 3×
“It is noteworthy that the mRNAs encoding several protein inhibitors of apoptosis (XIAP, c-IAP1 and BCl-2) and pro-apoptotic proteins (c-Myc, APAF-1) contain internal ribosomal entry sites (IRES), which serve to sustain translation during apoptosis, when cap-dependent expression is suppressed (reviewed in Proud, 2004).”
BackgroundTargeting the molecular target of rapamycin (mTOR)
Rowinsky, E. K. (2004) · Current Opinion in Oncology · doi:10.1097/01.cco.0000143964.74936.d1 · Cited by 155 · cited 1×
“Several clinical trials involving rapamycin analogs are currently under way and show promising results (reviewed in Rowinsky, 2004; Young and Nickerson-Nutter, 2005; Thomas, 2006).”
BackgroundmTOR Controls FLIPS Translation and TRAIL Sensitivity in Glioblastoma Multiforme Cells
Panner, A., James, C. D., Berger, M. S., & Pieper, R. O. (2005) · Molecular and Cellular Biology · doi:10.1128/mcb.25.20.8809-8823.2005 · Cited by 154 · cited 4×
“In a recent study, Panner et al. (Panner et al., 2005, 2006) reported that resistance to TRAIL-induced apoptosis is associated with reduced expression of the anti-apoptotic FLICE like inhibitory proteins (FLIPS) and decreased S6K phosphorylation.”
BackgroundInfluentialRaptor and mTOR: Subunits of a Nutrient-Sensitive Complex
Kim, D., & Sabatini, D. M. (2004) · Current topics in microbiology and immunology · doi:10.1007/978-3-642-18930-2_15 · Cited by 148 · cited 1×
“…et al., 2005; Stephens et al., 2005; Petroulakis et al., 2006) (Figure 2). mTOR promotes the phosphorylation and activation of S6K and the hierarchial phosphorylation the 4E-BPs (Gingras et al., 2001; Jacinto and Hall, 2003; Kim et al., 2003; Ruggero and Pandolfi, 2003; Kim and Sabatini, 2004).”
BackgroundWarnakulasuriyarachchi, D., Cerquozzi, S., Cheung, H. H., & Holcík, M. (2004) · Journal of Biological Chemistry · doi:10.1074/jbc.m308737200 · Cited by 140 · cited 1×
“When cleaved by caspases, p97/NAT-1/ DAP5 promotes the translation of IRES-dependent mRNAs whose products are involved in apoptosis such as those encoding for c-Myc, XIAP, APAF-1 (Henis-Korenblit et al., 2002) and HIAP2 (Warnakulasuriyarachchi et al., 2004).”
BackgroundTee, A. R., & Proud, C. G. (2002) · Molecular and Cellular Biology · doi:10.1128/mcb.22.6.1674-1683.2002 · Cited by 139 · cited 1×
“The cleaved 4E-BP1 binds strongly to eIF4E, fails to become sufficiently phosphorylated and thus inhibits cap-dependent translation (Tee and Proud, 2002; Proud, 2005).”
BackgroundHu, C., Pang, S., Kong, X., Velleca, M., & Lawrence, J. C. (1994) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.91.9.3730 · Cited by 137 · cited 2×
“The mammalian eIF4E-binding proteins, 4E-BP1 (also referred to as PHAS-I for Phosphorylated Heat and Acid-Stable protein regulated by Insulin) and 4E-BP2, were identified in a screen using radiolabelled recombinant eIF4E protein to probe a human placenta expression library (Pause et al., 1994) and by sequencing the co…”
BackgroundRole of mTOR Signalling in the Control of Translation Initiation and Elongation by Nutrients
Proud, C. G. (2004) · Current topics in microbiology and immunology · doi:10.1007/978-3-642-18930-2_13 · Cited by 132 · cited 1×
“…the mRNAs encoding several protein inhibitors of apoptosis (XIAP, c-IAP1 and BCl-2) and pro-apoptotic proteins (c-Myc, APAF-1) contain internal ribosomal entry sites (IRES), which serve to sustain translation during apoptosis, when cap-dependent expression is suppressed (reviewed in Proud, 2004).”
BackgroundZhou, H. Y., & Wong, A. S. T. (2006) · Endocrinology · doi:10.1210/en.2005-1404 · Cited by 129 · cited 3×
“Recent studies have addressed the specific role of S6K1 in tumor invasiveness, motility and angiogenesis (Skinner et al., 2004; Zhou and Wong, 2006).”
BackgroundShi, J., Kahle, A. C., Hershey, J. W. B., Honchak, B. M., Warneke, J. A., Leong, S. P. L., & Nelson, M. A. (2006) · Oncogene · doi:10.1038/sj.onc.1209495 · Cited by 122 · cited 1×
“A recent study on eIF3f, the p47 subunit of the multi-subunit eIF3 complex, showed that it exhibits pro-apoptotic properties, as its overexpression inhibited cell proliferation and induced apoptosis in melanoma and pancreatic cancer cells (Shi et al., 2006).”
BackgroundOkamoto, H., Yasui, K., Zhao, C., Arii, S., & Inazawa, J. (2003) · Hepatology · doi:10.1053/jhep.2003.50457 · Cited by 116 · cited 1×
“…(Eberle et al., 1997; Shuda et al., 2000). eIF3 has also been implicated in cellular transformation in breast, liver and prostate cancers (Okamoto et al., 2003; Savinainen et al., 2004). mTOR signaling and cancer Growth factors, mitogens and hormones activate the PI3K/AKT/mTOR signaling…”
BackgroundPhosphoinositide 3-kinases as drug targets in cancer
Stephens, L., WILLIAMS, R., & Hawkins, P. T. (2005) · Current Opinion in Pharmacology · doi:10.1016/j.coph.2005.03.002 · Cited by 115 · cited 1×
“An important downstream target of this signaling pathway is cap-dependent mRNA translation (Hay and Sonenberg, 2004; Hennessy et al., 2005; Stephens et al., 2005; Petroulakis et al., 2006) (Figure 2). mTOR promotes the phosphorylation and activation of S6K and the hierarchial phosphorylation the…”
BackgroundLi, S., Takasu, T., Perlman, D. M., Peterson, M. S., Burrichter, D., Avdulov, S., Bitterman, P. B., & Polunovsky, V. A. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.m208821200 · Cited by 113 · cited 2×
“…cell survival and cell death. eIF4E plays an important role in the control of this balance (Tan et al., 2000; Clemens, 2001; Dua et al., 2001; Li et al., 2003, 2004). eIF4E overexpression compensates for serum/growth factor deprivation by promoting the survival of NIH 3T3 cells (Polunovsky…”
BackgroundTranslational Control of the Antiapoptotic Function of Ras
Polunovsky, V. A., Gingras, A.-C., Sonenberg, N., Peterson, M., Tan, A., Rubins, J. B., Manivel, J. C., & Bitterman, P. B. (2000) · Journal of Biological Chemistry · doi:10.1074/jbc.m001938200 · Cited by 111 · cited 2×
“The 4E-BPs promote apoptosis: ectopic expression of 4E-BP1 induces apoptosis in both normal and Ras-transformed fibroblasts (Polunovsky et al., 2000; Li et al., 2002).”
BackgroundSelf-citationTan, A., Bitterman, P. B., Sonenberg, N., Peterson, M., & Polunovsky, V. A. (2000) · Oncogene · doi:10.1038/sj.onc.1203446 · Cited by 110 · cited 3×
“…anti-apoptotic functions can alter the balance between cell survival and cell death. eIF4E plays an important role in the control of this balance (Tan et al., 2000; Clemens, 2001; Dua et al., 2001; Li et al., 2003, 2004). eIF4E overexpression compensates for serum/growth factor deprivation by…”
BackgroundSelf-citationYan, H., Frost, P., Shi, Y., Hoang, B., Sharma, S., Fisher, M., Gera, J., & Lichtenstein, A. (2006) · Cancer Research · doi:10.1158/0008-5472.can-05-2447 · Cited by 108 · cited 1×
“Furthermore, a non-phosphorylatable mutant of 4E-BP1 mutant, in which the critical phosphorylation site threonine and serine amino acids were mutated to alanines, sensitizes multiple myeloma cells to dexamethasone-induced apoptosis (Yan et al., 2006).”
BackgroundLi, S., Sonenberg, N., Gingras, A.-C., Peterson, M., Avdulov, S., Polunovsky, V. A., & Bitterman, P. B. (2002) · Molecular and Cellular Biology · doi:10.1128/mcb.22.8.2853-2861.2002 · Cited by 99 · cited 1×
“The 4E-BPs promote apoptosis: ectopic expression of 4E-BP1 induces apoptosis in both normal and Ras-transformed fibroblasts (Polunovsky et al., 2000; Li et al., 2002).”
BackgroundSelf-citationTranslational regulation in cell stress and apoptosis. Roles of the eIF4E binding proteins
Clemens, M. J. (2001) · Journal of Cellular and Molecular Medicine · doi:10.1111/j.1582-4934.2001.tb00157.x · Cited by 98 · cited 1×
“…can alter the balance between cell survival and cell death. eIF4E plays an important role in the control of this balance (Tan et al., 2000; Clemens, 2001; Dua et al., 2001; Li et al., 2003, 2004). eIF4E overexpression compensates for serum/growth factor deprivation by promoting the…”
BackgroundDilling, M. B., Germain, G. S., Dudkin, L., Jayaraman, A. L., Zhang, X., Harwood, F. C., & Houghton, P. J. (2002) · Journal of Biological Chemistry · doi:10.1074/jbc.m110782200 · Cited by 96 · cited 1×
“Rapamycin-resistant rhabdomyosarcoma cells (Dilling et al., 2002) express low levels of 4E-BP1, do not exhibit rapamycin-inducible c-Jun NH2-terminal kinase (JNK) activation and are resistant to apoptosis (Huang et al., 2003).”
BackgroundBauer, C., Brass, N., Diesinger, I., Kayser, K., Grässer, F. A., & Meese, E. U. (2001) · International Journal of Cancer · doi:10.1002/ijc.10180 · Cited by 88 · cited 1×
“…factors might be implicated in tumorigenesis: eIF4GI is overexpressed in squamous cell lung carcinomas (Brass et al., 1997; Keiper et al., 1999; Bauer et al., 2001, 2002), and eIF4GI transforms NIH 3T3 cells (Fukuchi-Shimogori et al., 1997). eIF4GI is a downstream target of mTOR as rapamycin…”
BackgroundExpression and copy number analysis of TRPS1, EIF3S3 and MYC genes in breast and prostate cancer
Savinainen, K., Linja, M. J., Saramäki, O. R., Tammela, T. L. J., Chang, G. T. G., Brinkmann, A. O., & Visakorpi, T. (2004) · British Journal of Cancer · doi:10.1038/sj.bjc.6601648 · Cited by 84 · cited 1×
“…(Eberle et al., 1997; Shuda et al., 2000). eIF3 has also been implicated in cellular transformation in breast, liver and prostate cancers (Okamoto et al., 2003; Savinainen et al., 2004). mTOR signaling and cancer Growth factors, mitogens and hormones activate the PI3K/AKT/mTOR signaling pathway.”
BackgroundTranslational control of the proteome: Relevance to cancer
Dua, K., Williams, T. M., & Beretta, L. (2001) · PROTEOMICS · doi:10.1002/1615-9861(200110)1:10<1191::aid-prot1191>3.0.co;2-8 · Cited by 82 · cited 1×
“…the balance between cell survival and cell death. eIF4E plays an important role in the control of this balance (Tan et al., 2000; Clemens, 2001; Dua et al., 2001; Li et al., 2003, 2004). eIF4E overexpression compensates for serum/growth factor deprivation by promoting the survival of NIH 3T3…”
BackgroundLynch, M., Fitzgerald, C., Johnston, K. A., Wang, S., & Schmidt, E. V. (2004) · Journal of Biological Chemistry · doi:10.1074/jbc.m310872200 · Cited by 73 · cited 1×
“This 4E-BP mutant also slows G1 progression, blocks c-myc-induced transformation (Lynch et al., 2004) and prevents tumor growth (Avdulov et al., 2004).”
BackgroundWang, F.-Q., So, J., Reierstad, S., & Fishman, D. A. (2005) · International Journal of Cancer · doi:10.1002/ijc.21421 · Cited by 71 · cited 1×
“VEGF is essential for both physiological and pathological angiogenesis in cancer, such as ovarian cancers (Paley et al., 1997; Wang et al., 2006).”
BackgroundBauer, C., Diesinger, I., Brass, N., Steinhart, H., Iro, H., & Meese, E. U. (2001) · Cancer · doi:10.1002/1097-0142(20010815)92:4<781::aid-cncr1383>3.0.co;2-p · Cited by 70
Protein synthesis initiation factor 4G
Keiper, B. D., Gan, W., & Rhoads, R. E. (1999) · The International Journal of Biochemistry & Cell Biology · doi:10.1016/s1357-2725(98)00130-7 · Cited by 66 · cited 1×
“…translation initiation factors might be implicated in tumorigenesis: eIF4GI is overexpressed in squamous cell lung carcinomas (Brass et al., 1997; Keiper et al., 1999; Bauer et al., 2001, 2002), and eIF4GI transforms NIH 3T3 cells (Fukuchi-Shimogori et al., 1997). eIF4GI is a downstream target…”
BackgroundOridate, N., Kim, H.-J., Xu, X., & Lotan, R. (2005) · Cancer Biology & Therapy · doi:10.4161/cbt.4.3.1504 · Cited by 62 · cited 1×
“…interfering RNA (siRNA) knockdown of eIF4E inhibits the growth of several cell lines, including those of head and neck squamous carcinoma cells (Oridate et al., 2005). eIF4E is thus a potential target for anticancer therapies. eIF4E levels in the cell are tightly controlled at several levels:…”
BackgroundLiver metastasis formation by laminin-1 peptide (LQVQLSIR)-adhesion selected B16-F10 melanoma cells
Song, S.-Y., Nomizu, M., Yamada, Y., & Kleinman, H. K. (1997) · International Journal of Cancer · doi:10.1002/(sici)1097-0215(19970502)71:3<364::aid-ijc10>3.0.co;2-g · Cited by 57
Translation Initiation Factor 4E Blocks Endoplasmic Reticulum-mediated Apoptosis
Li, S., Perlman, D. M., Peterson, M. S., Burrichter, D., Avdulov, S., Polunovsky, V. A., & Bitterman, P. B. (2004) · Journal of Biological Chemistry · doi:10.1074/jbc.m312467200 · Cited by 44 · cited 2×
“…cell survival and cell death. eIF4E plays an important role in the control of this balance (Tan et al., 2000; Clemens, 2001; Dua et al., 2001; Li et al., 2003, 2004). eIF4E overexpression compensates for serum/growth factor deprivation by promoting the survival of NIH 3T3 cells (Polunovsky…”
BackgroundYOUNG, D., & Nickerson‐Nutter, C. L. (2005) · Current Opinion in Pharmacology · doi:10.1016/j.coph.2005.03.004 · Cited by 42 · cited 2×
“Oncogene and is used in clinical applications such as transplantation and restenosis (Young and Nickerson-Nutter, 2005).”
BackgroundMethodThe eukaryotic initiation factor 4E-binding proteins and apoptosis
Proud, C. G. (2005) · Cell Death and Differentiation · doi:10.1038/sj.cdd.4401588 · Cited by 41 · cited 1×
“The cleaved 4E-BP1 binds strongly to eIF4E, fails to become sufficiently phosphorylated and thus inhibits cap-dependent translation (Tee and Proud, 2002; Proud, 2005).”
BackgroundeIF3: A ConnecTOR of S6K1 to the Translation Preinitiation Complex
Peterson, T. R., & Sabatini, D. M. (2005) · Molecular Cell · doi:10.1016/j.molcel.2005.11.016 · Cited by 24 · cited 1×
“A new connection between the mTOR/S6K1 pathway and translation initiation has been demonstrated recently (Holz et al., 2005; Peterson and Sabatini, 2005).”
BackgroundTranslational Regulation of TRAIL Sensitivity
Panner, A., Parsa, A. T., & Pieper, R. O. (2005) · Cell Cycle · doi:10.4161/cc.5.2.2359 · Cited by 19 · cited 4×
“In a recent study, Panner et al. (Panner et al., 2005, 2006) reported that resistance to TRAIL-induced apoptosis is associated with reduced expression of the anti-apoptotic FLICE like inhibitory proteins (FLIPS) and decreased S6K phosphorylation.”
BackgroundInfluential
Research works printed but not linked: 2
- Bauer C, Diesinger I, Brass N, Steinhart H, Iro H, Meese EU . (2001). Cancer 92: 822–829. · DOI · Paper page
- Eberle J, Krasagakis K, Orfanos CE . (1997). Int J Cancer 71: 396–401. · DOI · Paper page
Cited by
Ingolia, N. T., Lareau, L. F., & Weissman, J. S. (2011) · Cell · doi:10.1016/j.cell.2011.10.002 · Cited by 2,187
“Polysome-profiling experiments have suggested a global increase in cellular translation during early ESC differentiation, and we see a modest upregulation of RPs in our early time point (Sampath et al., 2008).”
BackgroundInfluentialAutosomal dominant polycystic kidney disease
Torres, V. E., Harris, P. C., & Pirson, Y. (2007) · The Lancet · doi:10.1016/s0140-6736(07)60601-1 · Cited by 1,550
Making new contacts: the mTOR network in metabolism and signalling crosstalk
Shimobayashi, M., & Hall, M. N. (2014) · Nature Reviews Molecular Cell Biology · doi:10.1038/nrm3757 · Cited by 1,053
Alao, J. P. (2007) · Molecular Cancer · doi:10.1186/1476-4598-6-24 · Cited by 871
“Mammalian target of rapamycin (mTOR) is a target of the phosphatidylinositol 3-Kinase (PI3K)/protein kinase B (PKB/Akt) pathway (reviewed in [121-126]) and plays a major role in coupling mitogenic stimuli to cell cycle progression.”
Mammalian target of rapamycin: a central node of complex signaling cascades.
Dobashi, Y., Watanabe, Y., Miwa, C., Suzuki, S., & Koyama, S. (2011) · PubMed · Cited by 750
Metadata
- Authors
- Mamane, Y., Petroulakis, E., LeBacquer, O., & Sonenberg, N.
- Affiliations
- McGill University (CA)
- Corresponding author
- Sonenberg, N
- ORCID
- Sonenberg, N
- Venue
- Oncogene
- Published
- 2006-10-16
- Volume
- 25
- Issue
- 48
- Pages
- 6416-6422
- ISSN
- 0950-9232 (ISSN-L)
- 1476-5594
- OpenAlex
- W2165848665
- Cited by
- 607
- References
- 79
- Citations by year
- 2026: 2 · 2025: 10 · 2024: 4 · 2023: 28 · 2022: 14 · 2021: 7 · 2020: 23 · 2019: 16 · 2018: 32 · 2017: 26 · 2016: 28 · 2015: 41 · 2014: 41 · 2013: 40 · 2012: 41
- FWCI
- 4.17
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- www.springer.com/tdm (tdm)
- www.springer.com/tdm (vor)
- Locations
- Oncogene (publishedVersion)
- PubMed (publishedVersion)
- HAL (submittedVersion)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › PI3K/AKT/mTOR signaling in cancer
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › RNA and protein synthesis mechanisms
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Metabolism, Diabetes, and Cancer
- Keywords
- mTOR, mRNA translation, translation initiation, PI3K/AKT/mTOR pathway, 4E-BP, S6K, cap-dependent translation, cancer therapy, nutrient signaling, cell growth
- MeSH terms
- Animals, Gene Expression Regulation, Humans, Mammals, Models, Genetic, Neoplasms, Peptide Chain Initiation, Translational, Protein Kinases, Signal Transduction, Phosphatidylinositol 3-Kinases, Ribosomal Protein S6 Kinases, TOR Serine-Threonine Kinases
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.